Repurposing auranofin as a Clostridioides difficile therapeutic

M. Hutton(Australian Regenerative Medicine Institute), Dena Lyras(Discovery Institute), Meagan L. James(Australian Regenerative Medicine Institute), Havva Pehlivanoglu(Australian Regenerative Medicine Institute), Callum J. Vidor(Australian Regenerative Medicine Institute), Melanie J. Thomson(Deakin University)
Journal of Antimicrobial Chemotherapy
October 9, 2019
10.1093/jac/dkz430
Cited by 28

Related Papers

Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
|Science|2005|2k
Auranofin: Repurposing an Old Drug for a Golden New Age
|Drugs in R&D|2015|499
A novel model of sensitization and oral tolerance to peanut protein
|Immunology|2004|122
The Nitric Oxide (NO)-Sensing Repressor NsrR of <i>Neisseria meningitidis</i> Has a Compact Regulon of Genes Involved in NO Synthesis and Detoxification
|Journal of Bacteriology|2008|67
Growth of rotaviruses in continuous human and monkey cell lines that vary in their expression of integrins
|Journal of General Virology|2000|58